Market cap
$1,114 Mln
Revenue (TTM)
$19 Mln
P/E Ratio
12.1
P/B Ratio
1
Div. Yield
11.4 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.1 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
--
-
Book Value
$20
-
EPS
$1.8
-
Face value
--
-
Shares outstanding
57,192,236
10 Years Aggregate
CFO
$-141.08 Mln
EBITDA
$611.16 Mln
Net Profit
$565.84 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
| 5.0 | 1.4 | 3.8 | 30.7 | 6.1 | -4.1 | -2.5 |
|
BSE Sensex
| -11.7 | -2.7 | -8.0 | -8.0 | 6.2 | 7.8 | 10.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
| 18.0 | -3.1 | -7.9 | -24.2 | -0.3 | 14.1 | 16.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
19.9 | 1,113.5 | 99.8 | 98.6 | 527.8 | 9.2 | 12.1 | 1.0 |
| 15.9 | 1,626.1 | 225.0 | 222.0 | -- | 13.4 | 7.3 | 1.0 | |
| 30.4 | 1,973.0 | 266.0 | 314.4 | -- | 20.3 | 6.2 | 1.1 | |
| 10.9 | 3,019.1 | 599.0 | -550.0 | -0.5 | -9.6 | -- | 0.6 | |
| 64.2 | 1,542.3 | 163.9 | 339.8 | 27.3 | 20.6 | 4.4 | 1.0 | |
| 13.6 | 2,396.5 | -42.2 | -46.9 | 60.8 | -1.9 | -- | 1.0 | |
| 16.8 | 1,256.3 | 325.8 | 321.3 | -- | 25.6 | 3.9 | 0.9 | |
| 2.4 | 1,142.3 | 99.4 | -37.8 | -83.0 | -1 | -- | 0.4 | |
| 17.4 | 1,708.9 | 101.9 | 174.1 | -- | 8 | 9.8 | 0.8 | |
| 35.3 | 1,855.7 | 204.6 | 254.3 | -- | 13.1 | 7.1 | 1.0 |
Shareholding Pattern
View DetailsAbout Tekla Healthcare Investors (HQH)
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the... biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States. Address: 1900 Market Street, Philadelphia, PA, United States, 19103 Read more
-
Portfolio Manager
Dr. Daniel R. Omstead M.S, Ph.D.
-
Portfolio Manager
Dr. Daniel R. Omstead M.S, Ph.D.
-
Headquarters
Philadelphia, PA
-
Website
FAQs for Tekla Healthcare Investors (HQH)
What is the current share price of Tekla Healthcare Investors (HQH) Today?
The share price of Tekla Healthcare Investors (HQH) is $19.88 (NYSE) as of 29-May-2026 11:46 EDT. Tekla Healthcare Investors (HQH) has given a return of 6.07% in the last 3 years.
What is the current PB & PE ratio of Tekla Healthcare Investors (HQH)?
The P/E ratio of Tekla Healthcare Investors (HQH) is 12.09 times as on 22-May-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
10.26
|
0.92
|
|
2024
|
5.40
|
0.94
|
|
2023
|
13.65
|
0.83
|
|
2022
|
-4.21
|
0.89
|
|
2021
|
7.49
|
1.00
|
What is the 52 Week High and Low of Tekla Healthcare Investors (HQH)?
The 52-week high and low of Tekla Healthcare Investors (HQH) are Rs 20.46 and Rs 15.09 as of 29-May-2026.
What is the market cap of Tekla Healthcare Investors (HQH)?
Tekla Healthcare Investors (HQH) has a market capitalisation of $ 1,114 Mln as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Tekla Healthcare Investors (HQH)?
Before investing in Tekla Healthcare Investors (HQH), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.